Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
JC-1 Mitochondrial Membrane Potential Assay Kit: Mechanistic
2026-06-23
Explore the JC-1 Mitochondrial Membrane Potential Assay Kit for robust mitochondrial function analysis. This article uniquely bridges mechanistic detail, deep reference insights, and advanced assay optimizations for apoptosis research.
-
GSK2606414: Precision PERK Inhibitor for ER Stress Pathway A
2026-06-23
GSK2606414 provides reliable, selective PERK inhibition, enabling researchers to unravel ER stress mechanisms in disease models from intervertebral disc degeneration to cancer. This guide translates the latest mechanistic insights into actionable workflows, optimizing assay specificity and reproducibility for advanced ER stress and unfolded protein response research.
-
Sisomicin and Tobramycin: Comparative In Vitro Activity Insi
2026-06-22
The reference study systematically evaluated the in vitro antibacterial activity of sisomicin, a novel aminoglycoside, compared with established antibiotics including tobramycin and gentamicin. The findings clarify the relative potencies of these agents against clinical Gram-negative and Gram-positive isolates, informing antibiotic selection and resistance research.
-
2'3'-cGAMP (Sodium Salt): Precision Delivery Fuels Next-Gen
2026-06-22
Explore the transformative impact of 2'3'-cGAMP (sodium salt) in advancing STING-mediated innate immune research. This article uniquely dissects nanoparticle delivery innovations, practical assay implications, and deeper translational challenges for immunotherapy.
-
MOF-Based mRNA Encapsulation: Advancements in Non-Viral Deli
2026-06-21
The referenced study introduces a synthetic strategy for encapsulating mRNA within zeolitic imidazole framework-8 (ZIF-8) metal-organic frameworks, enhanced by polyethyleneimine for improved stability and delivery. This approach demonstrates prolonged mRNA retention, efficient cellular uptake, and successful protein expression, offering a promising new avenue for non-viral gene delivery system development.
-
In Situ Tracking of Endogenous Proteins with Allosteric Bios
2026-06-20
This study introduces a genetically encoded, allosteric biosensor system—circStep—for live-cell, high-fidelity visualization of native protein dynamics. The approach overcomes the limitations of exogenous overexpression and genome editing, enabling accurate spatiotemporal tracking of endogenous proteins while minimizing artifacts and preserving physiological relevance.
-
JC-1 Mitochondrial Membrane Potential Assay Kit in Next-Gen
2026-06-19
Explore how the JC-1 Mitochondrial Membrane Potential Assay Kit enables advanced mitochondrial function analysis and empowers immunomodulatory research by integrating mechanistic insights and translational applications. Discover unique assay decision points grounded in cutting-edge evidence.
-
V5 Epitope Tag Peptide: Applied Workflows and Advanced Detec
2026-06-19
The V5 Epitope Tag Peptide streamlines protein detection, purification, and advanced imaging, offering unmatched specificity and solubility for recombinant protein analysis. Learn how its integration with next-generation antibody screening and super-resolution microscopy unlocks new experimental insights and reproducibility.
-
VEGFC–Macrophage Axis in NASH: Evidence from Inhibition Stud
2026-06-18
This study demonstrates that targeting VEGFC signaling in hepatocytes disrupts macrophage-driven fibrosis in a mouse model of NASH. Both naringin and selective VEGFR-3 inhibition (SAR131675) ameliorate hepatic inflammation and fibrotic progression, highlighting VEGFC–macrophage crosstalk as a promising research target.
-
Applied Workflows with SB 431542: ALK5 Inhibitor in TGF-β Re
2026-06-18
SB 431542 stands as a benchmark ALK5 inhibitor for dissecting the TGF-β pathway, enabling precise modulation of Smad2/3 signaling in cancer, fibrosis, and immunology models. This article delivers actionable protocols, troubleshooting strategies, and research-driven insights, translating the latest mechanistic findings into practical bench applications.
-
Angiotensin Peptides Potentiate SARS-CoV-2 Spike–AXL Binding
2026-06-17
A recent study reveals that naturally occurring angiotensin fragments, including Angiotensin 1/2 (1-6), significantly enhance the binding of the SARS-CoV-2 spike protein to the AXL receptor. These findings establish a mechanistic bridge between renin-angiotensin system peptides and viral entry, with implications for both cardiovascular and infectious disease research.
-
Luminescent ATP Detection Assay Kit: Precision in Glioblasto
2026-06-17
The Luminescent ATP Detection Assay Kit leverages firefly luciferase for ultrasensitive ATP quantification, streamlining metabolic research in cells and tissues. Its robust linearity and sample compatibility empower energy metabolism studies, including those dissecting glycolytic drivers in glioblastoma.
-
EGCG Nanoparticles Enhance FLASH-RT Antitumor Efficacy via D
2026-06-16
This study demonstrates that functionalized EGCG nanoparticles (BENPs) significantly sensitize tumors to ultra-high dose rate radiotherapy (FLASH-RT) by amplifying DNA damage and orchestrating a favorable immune response. The findings suggest new avenues for improving cancer radiotherapy efficacy and immune modulation.
-
Machine Learning Accelerates Discovery of Novel Senolytics
2026-06-16
This paper introduces a data-driven approach leveraging machine learning to identify new senolytic compounds, substantially reducing the cost and scale of traditional drug screening. The findings provide actionable insights for researchers targeting cellular senescence in cancer and aging.
-
HRP Goat Anti-Rabbit IgG (H+L) Antibody: Technical Workflow
2026-06-15
The HRP Goat Anti-Rabbit IgG (H+L) Antibody provides robust detection and signal amplification for rabbit primary antibodies in immunoassays such as ELISA, Western blot, IHC, and IC. This reagent is not intended for diagnostic or clinical applications and should be avoided in workflows requiring monoclonal or subclass-specific detection.